Quick Summary
Bdparp 150mg Tablet 56'S
Last updated on 31 Mar 2026 | 09:30 AM (IST)
₹40500
MRP: ₹50625
(You Save ₹10125)
56 TABLET(s) IN A BOTTLE
Bdparp 150mg Tablet 56'S
Salt Composition
OLAPARIBMarketer
BDR PHARMACEUTICALS INTERNATIONALS PVT LTD
20% OFF
₹40500
MRP: ₹50,625.00
Inclusive of all taxes
20% Off
Substitutes
Olanamo 150mg Tablet
SHIVNAAM TRADEL...
₹ 95.97/tablet
86% cheaper
Zeparib 150mg Tablet
ZEE LABORATORIE...
₹ 98.47/tablet
86% cheaper
Olzapar 150mg Tablet
DELARC PHARMACE...
₹ 132.55/tablet
81% cheaper
Ibyra 150mg Tablet
ZYDUS CADILA
₹ 136.18/tablet
81% cheaper
Introduction to Bdparp 150mg Tablet 56'S
Bdparp tablet is an antiviral drug belonging to the category of poly adenosine diphosphate-ribose polymerase (PARP) inhibitor, containing the active ingredient Olaparib. It is used to treat pancreatic, and prostate cancer. Cancer is a disease in which cells multiply uncontrollably and abnormally. This medication can be given alone or in combination with other anticancer medications.
Speak with your doctor immediately if you experience breathlessness, chest pain, rapid heart rate, fever, cough, or wheezing. Your healthcare provider will conduct blood tests before and every month during the treatment, as this medicine could reduce the counts of RBC, WBC, and platelets. Tell your healthcare provider before starting treatment if you have been diagnosed with problems in your lungs, liver, heart, or kidneys.
This drug is not recommended during pregnancy as it might harm the unborn baby and lead to miscarriage. Hence, it is advisable to do a pregnancy test before starting this treatment for women of childbearing age. Ideally, it is better to continue birth control methods for a minimum of 6 months after completion of the treatment. Avoid breastfeeding your baby while you are on the treatment, as it is unknown whether the Bdparp tablet passes into the breast milk.
Uses of Bdparp 150mg Tablet 56'S
- Prostate cancer
- Pancreatic cancer
Therapeutic Effects of Bdparp 150mg Tablet 56'S
Bdparp tablet works by inhibiting PARP enzymes, blocks the repair of single-stranded DNA, and ultimately hinders the growth and development of cancer cells.
Interaction of Bdparp 150mg Tablet 56'S with other drugs
Inform your healthcare provider about all the medicines you take, including prescription, over-the-counter, nutritional or vitamin supplements, and herbal products. Certain medications may interact with Bdparp tablets and reduce effectiveness by causing undesirable side effects.
More Information about Bdparp 150mg Tablet 56'S
- Store the Bdparp tablet in the original package at room temperature (20°C to 25°C).
- Keep it out of reach from children.
How to consume Bdparp 150mg Tablet 56'S
A healthcare professional in a hospital setting will prescribe the medicine to you. The Bdparp tablet can be taken with or without food, as directed by your healthcare provider. The usual recommended dosage is 250 mg once daily. Avoid crushing, opening, or dissolving the tablet; swallow it whole with a glass of water. Take the Bdparp tablet at the same time every day.
Safety Advice for Bdparp 150mg Tablet 56'S
Breast Feeding
Avoid breastfeeding your baby while on the treatment, as it is unknown whether Bdparp tablet passes into the breast milk. Please consult your doctor before breastfeeding.
Alcohol
It is unknown whether consuming alcohol interacts with the Bdparp tablet. Please consult your doctor for more advice.
Liver
Consult your doctor if you have any lung diseases before starting the treatment with Bdparp tablet.
Lungs
Whether Bdparp tablet can be used for patients with liver disorders is unknown. Inform your physician if you have any liver problems before starting the treatment.
Driving
It is unsafe to drive vehicles or operate heavy machinery after taking the Bdparp tablet because it contains a small amount of alcohol, which may cause dizziness and impair concentration.
Pregnancy
It is unsafe to use during pregnancy whether Bdparp tablet can be taken during pregnancy. Consult your doctor if you are pregnant or planning for pregnancy during the treatment.
Side Effects of Bdparp 150mg Tablet 56'S
Side effects are unwanted symptoms caused by medicines. Even though all drugs cause side effects, not everyone gets them.
Common:
- Diarrhea
- Nausea
- Vomiting
- Loss of appetite
- Weakness
- Red or sore mouth
- Increased liver enzymes
- Itchy or cracked skin
- Dry mouth
- Red or itchy eyes
- Nail problems
- Hair loss
- Fever
- Blood in the urine and a burning sensation while urinating
Word of Advice
Bdparp tablet can reduce blood cell counts, so it is advisable to be prompt during blood check-ups. Avoid direct exposure to sunlight during this therapy, and apply sunscreen above SPF 50 before stepping out. Do not stop taking the Bdparp tablet without consulting your doctor. Avoid grapefruit juice during treatment with this drug since it may increase the drug concentration level in your blood.
FAQs about Bdparp 150mg Tablet 56'S
Q1.
How effective is Bdparp tablet?
Bdparp tablet and other PARP inhibitors effectively prevent ovarian cancer relapse by 40-70%.
Q2.
What type of medication is Bdparp tablet?
Bdparp tablet is a targeted anticancer drug belonging to the category of PARP inhibitors. It specifically acts against ovarian cancer due to mutation in BRCA genes.
Q3.
How long should you take PARP inhibitors?
PARP inhibitors are intended to be taken for as long as your healthcare provider recommends. Some studies suggest taking PARP inhibitors for up to 2 years.
Q4.
Is Bdparp tablet used as a standalone treatment in cancers?
Bdparp tablet is usually indicated as maintenance therapy after a person completes a platinum-based chemotherapy regimen for ovarian cancer. However, newer studies are evaluating its solitary efficacy in treating different types of cancers.
Q5.
What are the long-term effects of the Bdparp tablet?
Bdparp tablet may increase the risk of bone marrow diseases (myelodysplastic syndrome or Acute Myeloid Leukemia), lung problems (pneumonitis), and blood clots (venous thromboembolism).
Fact Box of Bdparp 150mg Tablet 56'S
Molecule name: Olaparib | Therapeutic class: Antineoplastic Agent |
Pharmacological class: Poly Adenosine Diphosphate-Ribose Polymerase (PARP) inhibitor | Indications: 1. Prostate cancer 2. Pancreatic cancer |
References
- AstraZeneca UK Limited, Electronic medicines compendium (EMC), [Revised on Jan 2021] [ Accessed on 10 May 2023], https://www.medicines.org.uk/emc/files/pil.9204.pdf
- AstraZeneca Pharmaceuticals LP, US Food and Drug Administration, [Revised on Jan 2018] [Accessed on 10 May 2023], https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/208558s001lbl.pdf
- Sylvia Bochum, Stephanie Berger, Uwe M Martens; Olaparib; Recent Results in Cancer Research; Published on 2018; [Accessed on 10 May 2023] https://pubmed.ncbi.nlm.nih.gov/30069770/
- Xiao Xia Guo et al.; The efficacy and safety of the drug Olaparib in the treatment of cancers: a meta-analysis of randomized controlled drug trials; Cancer Management and Research; Published on Aug 2018;[Accessed on 10 May 2023] https://pubmed.ncbi.nlm.nih.gov/30127642/
- Sebastiaan C. Goulooze et al, Olaparib, Br J Clin Pharmaco, 81:1, 171-173, https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4693566/pdf/BCP-81-171.pdf
Disclaimer
MrMed’s primary intention is to ensure that its consumers get information that is reviewed by experts, accurate and trustworthy. The information and contents of this website are for informational purposes only. They are not intended to be a substitute for professional medical advice, diagnosis, or treatment. Please seek the advice of your doctor and discuss all your queries related to any disease or medicine. Do not disregard professional medical advice or delay in seeking it because of something you have read on MrMed. Our mission is to support, not replace, the doctor-patient relationship.
Did you find this information helpful?
Author Details
Written By
Dr. Deva Prasath S.
Pharm D
Reviewed By
Dr. Tejashwin Adiga
MBBS
Last updated : 31 Mar 2026 | 09:30 AM (IST)
Want to know more?
Read Our Editorial Policy
